Supplementary MaterialsSupp Desk S1. Oncology Group efficiency rating of 2). The entire response price was 78% with 12 full reactions (52%). At a median follow-up of 29 weeks, the median general success was 10.2 months as well as the median progression-free survival was 5.4 months. The most frequent grade 3/4 undesirable events had been haematological.… Continue reading Supplementary MaterialsSupp Desk S1. Oncology Group efficiency rating of 2). The